In a new study of the impact of Type 2 diabetes on body composition, older adults with diabetes — especially women — were at increased risk for excessive loss of skeletal muscle and trunk fat mass.

Hope everyone had a great Thanksgiving, with family and friends. As Steve and I were talking over the weekend we got into a discussion about people’s concern for their health between now and the first of the year. People get ready for the onslaught of food and parties in different …

by Reina Natero, University of Florida, PharmD Candidate, 2010 1.    What therapy indicated to improve glycemic control in adults with Type 2 diabetes mellitus is in the news this month? A small percentage of the total number of patients who have used the drug Byetta (exenatide) are the subject of …

Determining Your Carb Ratio Last week we provided you with a tool to determine your patients’ Insulin Sensitivity Factor. This week we are providing you the information to determine your patients’ carb-ratio. These two formulas will provide your patients with a convenient way to determine their insulin doses if they …

Americans Eat 22 Teaspoons of Sugar Daily. According to the National Health and Nutrition Examination Survey (NHANES), Americans on average eat and drink about 22 teaspoons (335 calories) of sugar daily. That’s almost a half cup of sugar a day, or about 130 to 140 pounds of sugar a year! …

Many patients with diabetes should forego angioplasties for heart disease and just take medicine instead, according to a new National Institutes of Health study led by Stanford University School of Medicine researcher Mark Hlatky, MD.

Higher HbA1c levels predict greater carotid intima-media thickness (IMT) in children and adolescents with Type 2 diabetes, new research shows.

A team led by scientists at The Scripps Research Institute have discovered a direct link between insulin — a hormone long associated with metabolism and metabolic disorders such as diabetes — and core body temperature.

A moderate-fat diet may work better than a low-fat regimen for people suffering from metabolic syndrome, a collection of conditions putting them at higher risk for cardiovascular disease, new research finds.

The latest results from a clinical trial with a SGLT Inhibitor demonstrates the major opportunity for this unique molecule to have an impact on treating diabetes. But even with this new class of drugs to fight diabetes, unless the patient is educated, they are still doomed for failure.